Dual-target Mesothelin/Claudin-18.2 CAR-T therapy

· Essen Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dual-target Mesothelin/Claudin-18.2 CAR-T therapy, covering 2025-07-15 to 2025-07-15. Get the full timeline:

Most recent: Clinical Trial Update: Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer [Phase 1, Phase 2]